简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-12-16 09:39 CAS Introducing Transformational Capabilities to Accelerate Life Sciences Innovation
2022-12-14 15:34 AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting
2022-12-14 15:25 Cancellation of remaining publicly held registered shares of Vifor Pharma AG
2022-12-14 09:43 European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares
2022-12-13 19:33 Reduced-risk* Potential of Velo as Cigarette Alternative Reinforced by Innovative Real-world Study
2022-12-13 19:30 Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
2022-12-13 19:25 Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases
2022-12-13 16:55 MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
2022-12-13 15:29 Masimo Announces Limited Market Release of Sepsis Index
2022-12-13 14:38 Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
2022-12-13 09:47 IWBI Launches the WELL Equity Rating to Advance Organizations and Places Where “Everyone Feels Welcome, Seen and Heard”
2022-12-13 09:18 International Conference on Display Technology (ICDT) Awards Universal Display Corporation with Excellent Paper Honor
2022-12-12 09:16 Aptorum Group Announces Offering of $3 Million Convertible Note due 2023
2022-12-09 19:23 Mary Kay Protects Critically Endangered Lemurs and Other Wildlife in Partnership With the Arbor Day Foundation
2022-12-09 09:51 Covetrus Names Ajoy Karna as Chief Financial Officer
2022-12-09 09:40 Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience
2022-12-08 18:42 ESF Seafood Transforms Shrimp Processing With Industry Leading Renewable Energy Conversion
2022-12-08 18:14 Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
2022-12-07 18:29 Affiliates of ZCG Acquire Universal Marine Medical Supply International
2022-12-07 18:25 Phase III trial demonstrated Jardiance is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes

Business Wire Weibo

Press Releases

Latest Releases